A Neural network approach to multi-biomarker panel development based on LC/MS/MS proteomics profiles: A case study in breast cancer

Proceedings - IEEE Symposium on Computer-Based Medical Systems

Volumn , Issue , 2009, Pages

  Zhang, Fan ^a,c   Chen, Jake Y ^a,b,c  

^a Indiana University   (United States)

^b Indiana University Purdue University Indianapolis   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL NEURAL NETWORK; BREAST CANCER; BREAST CANCER DIAGNOSIS; DATA ANALYSIS METHODS; DETECTABILITY; GENERAL MODEL; HUMAN DISEASE; INHERENT VARIABILITY; LC/MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; MARKER PROTEINS; PREDICTION PERFORMANCE; PROTEOMICS; RECEIVER OPERATING CHARACTERISTICS; STANDARD ANALYSIS; TECHNOLOGY PLATFORMS; TESTING DATA;

AMINES; BIOMARKERS; CHROMATOGRAPHIC ANALYSIS; COMPUTATIONAL METHODS; DIAGNOSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR BIOLOGY; NEURAL NETWORKS; PLASMAS; PROTEINS; REGRESSION ANALYSIS; STATISTICAL TESTS;

ANALYSIS OF VARIANCE (ANOVA);

EID: 70449632949     PISSN: 10637125     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/CBMS.2009.5255456     Document Type: Conference Paper

References (20)

1. R. Aebersold, and M. Mann, "Mass spectrometry-based proteomics," Nature, vol.422, no.6928, pp. 198-207, Mar 13, 2003.
2. J. D. Wulfkuhle, K. C. McLean, C. P. Paweletz et al, "New approaches to proteomic analysis of breast cancer," Proteomics, vol.1, no.10, pp. 1205-1215, Oct, 2001.
3. M. V. Dwek, and A. A. Alaiya, "Proteome analysis enables separate clustering of normal breast, benign breast and breast cancer tissues," Br J Cancer, vol.89, no.2, pp. 305-307, Jul 21, 2003.
4. S. Saha, S. H. Harrison, C. Shen et al., "HIP2: An online database of human plasma proteins from healthy individuals," BMC Med Genomics, vol.1, pp. 12, 2008.
5. A. Vlahou, C. Laronga, L. Wilson et al, "A novel approach toward development of a rapid blood test for breast cancer," Clin Breast Cancer, vol.4, no.3, pp. 203-209, Aug, 2003.
6. I. Anagnostopoulos, and I. Maglogiannis, "Neural network-based diagnostic and prognostic estimations in breast cancer microscopic instances," Med Biol Eng Comput, vol.44, no.9, pp. 773-784, Sep, 2006.
7. J. A. Baker, P. J. Kornguth, J. Y. Lo et al, "Breast cancer: prediction with artificial neural network based on BIRADS standardized lexicon," Radiology, vol.196, no.3, pp. 817-822, Sep, 1995.
8. C L. Chi, W. N. Street, and W. H. Wolberg, "Application of artificial neural network-based survival analysis on two breast cancer datasets," AMIA Annu Symp Proc, pp. 130-134, 2007.
9. P. J. Kersey, J. Duarte, A. Williams et al, "The International Protein Index: an integrated database for proteomics experiments," Proteomics, vol.4, no.7, pp. 1985-1988, Jul, 2004.
10. R. E. Higgs, M. D. Knierman, V. Gelfanova et al, "Comprehensive label-free method for the relative quantification of proteins from biological samples," J Proteome Res, vol.4, no.4, pp. 1442-1450, Jul-Aug, 2005.
11. M. Wang, J. You, K. G. Bemis et al, "Label-free mass spectrometry-based protein quantification technologies in proteomic analysis," Brief Funct Genomic Proteomic, vol.7, no.5, pp. 329-339, Sep, 2008.
12. A. E. Davis, 3rd, "Biological effects of C1 inhibitor," Drug News Perspect, vol.17, no.7, pp. 439-446, Sep, 2004.
13. M. Cicardi, L. Zingale, A. Zanichelli et al, "C1 inhibitor: molecular and clinical aspects," Springer Semin Immunopathol, vol.27, no.3, pp. 286-298, Nov, 2005.
14. X. Liang, J. Huuskonen, M. Hajivandi et al., "Identification and quantification of proteins differentially secreted by a pair of normal and malignant breast-cancer cell lines," Proteomics, vol.9, no.1, pp. 182-193, Jan, 2009.
15. O. Roeise, S. Sivertsen, T. E. Ruud et al., "Studies on components of the contact phase system in patients with advanced gastrointestinal cancer," Cancer, vol.65, no.6, pp. 1355-1359, Mar 15, 1990.
16. Y. Kanoh, N. Ohtani, T. Mashiko et al, "Levels of alpha 2 macroglobulin can predict bone metastases in prostate cancer," Anticancer Res, vol. 21, no. 1B, pp. 551-6, Jan-Feb, 2001.
17. J. N. Kloth, A. Gorter, G. J. Fleuren et al., "Elevated expression of SerpinAl and SerpinA3 in HLA-positive cervical carcinoma," J Pathol, vol.215, no.3, pp. 222-230, Jul, 2008.
18. E. Tahara, H. Ito, K. Taniyama et al, "Alpha 1-antitrypsin, alpha 1-antichymotrypsin, and alpha 2-macroglobulin in human gastric carcinomas: a retrospective immunohistochemical study," Hum Pathol, vol.15, no.10, pp. 957-964, Oct, 1984.
19. [19] T. Emoto, K. Nakamura, Y. Nagasaka et al., "Alpha 1-antichymotrypsin inhibits chymotrypsin-induced apoptosis in rat hepatoma cells," Apoptosis, vol.3, no.3, pp. 155-160, 1998. (Pubitemid 128513158)
20. T. J. Mariáni, V. Budhraja, B. H. Mecham et al., "A variable fold change threshold determines significance for expression microarrays," FASEB J, vol.17, no.2, pp. 321-323, Feb, 2003.